The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for ...
The US Food and Drug Administration approves Novo Nordisk's weight-loss pill, giving the Danish drugmaker a leg up in the ...
The FDA has approved the first daily pill for obesity treatment, offering a new alternative to injectable weight loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback